Healthcare Private Equity Soars to Record $191 Billion in 2025: What’s Driving the Boom and What to Expect in 2026
2026/01/08 23:15:14
Global healthcare private equity investment reached an unprecedented $191 billion in 2025, surpassing the previous peak in 2021, according to a recent report from Bain & Co. This surge signals a renewed confidence in the sector and sets the stage for continued robust activity in 2026.But what exactly is fueling this boom, and what does it mean for the future of healthcare?
Record-Breaking Dealmaking in 2025
The past year witnessed a critically important uptick in healthcare private equity deals across all segments. A total of 445 buyouts were recorded – the second-highest number on record – demonstrating a strong appetite for investment in the industry. This activity was particularly pronounced in the biopharma and healthcare provider sectors, driven by rapid advancements and increasing demand for healthcare IT solutions.
“Healthcare private equity delivered a record performance last year as large deals spiked and deal count rose across all tiers, with the biopharma and provider segments leading the way, driven by healthcare IT activity,” explained Kara Murphy, a partner at Bain and co-leader of its healthcare private equity team, in a news release.
The rebound of Exits
Perhaps even more telling than the increase in buyouts was the dramatic rebound in exit value. After a dip in 2024, exit value soared to $156 billion in 2025, a significant increase from the $54 billion recorded the previous year. This resurgence was largely attributed to the return of sponsor-to-sponsor transactions – where one private equity firm sells a portfolio company to another – indicating a healthy and active market. More than 30 sponsor-to-sponsor deals exceeded $1 billion in value, a significant jump from the eight such deals in 2024.
Regional Trends: A Global Phenomenon
The surge in healthcare private equity wasn’t limited to a single region. While North America remained a dominant force, with 26 transactions exceeding $1 billion despite a slow second quarter, Europe experienced particularly strong growth. Deal value in Europe doubled year-over-year, reaching $59 billion, largely fueled by activity in the biopharma space. Even Asia-Pacific saw record deal volume, demonstrating the global appeal of healthcare investments.
Sector Breakdown: Where the Money is Flowing
The $191 billion in deal value was distributed across various healthcare sub-sectors:
- Biopharma: $80 billion
- Provider & Related Services: $62 billion
- Healthcare IT: $32 billion
- Medtech: $33 billion
This breakdown highlights the growing importance of technology and innovation in healthcare, with significant investment flowing into areas like digital health, data analytics, and personalized medicine.
What’s Driving the Boom?
Several factors contributed to the record-breaking year for healthcare private equity:
- aging Populations: Globally,populations are aging,leading to increased demand for healthcare services and products.
- Technological Advancements: Breakthroughs in areas like genomics, artificial intelligence, and telehealth are creating new investment opportunities.
- Strong Fundamentals: Despite economic uncertainties, the healthcare sector is generally considered resilient and less susceptible to economic downturns.
- Dry Powder: Private equity firms are sitting on record levels of “dry powder” – uninvested capital – eager to deploy into attractive opportunities.
- Favorable Exit Environment: The rebound in exit value demonstrates that investors can successfully monetize their healthcare investments.
Looking Ahead to 2026: Continued Optimism
Industry experts remain optimistic about the outlook for healthcare private equity in 2026. Nirad Jain, also a partner at Bain, noted, “We are optimistic about the outlook for healthcare private equity this year, particularly given investor confidence in market fundamentals remained high in the face of headwinds last spring.”
Several trends are expected to shape the landscape in the coming year:
- continued M&A Activity: Public-to-private transactions and carve-out deals are expected to remain strong.
- Focus on Value Creation: Investors will increasingly focus on companies with clear value-creation strategies and the ability to deliver outsized returns.
- Increased Competition: As more capital flows into the sector, competition for attractive assets will intensify.
- Emphasis on healthcare IT: Investments in healthcare IT are likely to continue to grow,driven by the need for greater efficiency,improved patient outcomes,and data-driven insights.
the healthcare private equity market is poised for another active year in 2026, driven by strong fundamentals, abundant capital, and a growing recognition of the sector’s potential.Investors who can identify and capitalize on emerging trends will be well-positioned to succeed in this dynamic and evolving landscape.
